Trial intelligence / Profile preview

PK Study of Oral Testosterone Undecanoate in Hypogonadal Men

NCT00911586Phase 2Completed

Sponsor
Clarus Therapeutics
Start
Jul 2009
Primary completion
Sep 2009
Modality
Hormone, Biologic
Countries
1
01

Overview

A Phase 2 trial of testosterone undecanoate in male hypogonadism, sponsored by Clarus Therapeutics. Started Jul 2009; status: completed.

02

Drugs

testosterone undecanoate
03

Conditions

male hypogonadism

Beyond the preview

Go deeper on NCT00911586.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00911586.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call